First Trust Advisors LP Reata Pharmaceuticals Inc Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$79.22 - $105.37 $2.35 Million - $3.12 Million
29,611 New
29,611 $3.02 Million
Q4 2021

Feb 08, 2022
SELL
$25.61 - $110.96 $101,057 - $437,848
-3,946 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$100.0 - $143.02 $394,600 - $564,356
3,946 New
3,946 $397,000
Q3 2020

Nov 05, 2020
SELL
$93.53 - $163.34 $730,469 - $1.28 Million
-7,810 Closed
0 $0
Q2 2020

Jul 22, 2020
SELL
$126.3 - $176.56 $3.01 Million - $4.21 Million
-23,870 Reduced 75.35%
7,810 $1.22 Million
Q1 2020

May 06, 2020
SELL
$124.16 - $247.74 $2.28 Million - $4.54 Million
-18,336 Reduced 36.66%
31,680 $4.57 Million
Q4 2019

Feb 03, 2020
SELL
$74.57 - $217.92 $612,965 - $1.79 Million
-8,220 Reduced 14.11%
50,016 $10.2 Million
Q3 2019

Nov 04, 2019
BUY
$71.26 - $95.75 $450,291 - $605,044
6,319 Added 12.17%
58,236 $4.68 Million
Q2 2019

Jul 30, 2019
BUY
$77.72 - $94.35 $2.05 Million - $2.49 Million
26,441 Added 103.79%
51,917 $4.9 Million
Q1 2019

May 09, 2019
SELL
$51.9 - $101.79 $1.13 Million - $2.21 Million
-21,722 Reduced 46.02%
25,476 $2.18 Million
Q4 2018

Feb 07, 2019
BUY
$48.76 - $76.44 $2.14 Million - $3.36 Million
43,976 Added 1364.87%
47,198 $2.65 Million
Q3 2018

Oct 25, 2018
BUY
$35.64 - $92.06 $114,832 - $296,617
3,222 New
3,222 $263,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email